- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06420583
Post Operative Pain and Oral Health Related Quality of Life Following Pulpotomy VS Extraction of Permanent First Molar
Post Operative Pain and Oral Health Related Quality of Life Following Pulpotomy VS Extraction for the Management of Permanent First Molar With Poor Prognosis: A Randomized Clinical Trial
The goal of this clinical trial is to compare between post operative pain and oral health related quality of life in participants receiving two treatments for first permanent mandibular molars with poor prognosis.
Group I (Experimental group): Complete Pulpotomy with the use of MTA followed by stainless steel crown.
Group II (Control group): Non-surgical extraction.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The principal investigator will carry out all treatment procedures, and the patients will be assigned.
For both interventions:
- Informed consent from participating parents.
- Baseline records photographs, percussion test, periapical and panoramic radiographs, and personal data collection.
- A diagnostic chart with personal, medical, and dental history will be filled
- Baseline Oral Health related quality of life questionnaire for each participant.
- A clinical examination will be performed to assess the clinical inclusion criteria. (Pulpal and periapical diagnoses are established after clinical examination).
- Preoperative and Postoperative photographs will be taken.
- The radiographic examination will be performed by taking a periapical radiograph and a Panoramic radiograph through a machine to assess the inclusion criteria. The preoperative radiograph will serve as a reference for the follow-up radiographs. Standardization of the technique to avoid any distortion in the vertical dimension and to provide reproducible images using an X-ray holding device.
- Preoperative and postoperative radiographs in the pulp therapy group will be taken by a parallel technique using an XCP film holder (Super Bite, Hawe Neos DentalSA, Switzerland).
- Participants will then be allocated into either one of the groups according to the indicated intervention needed as follows:
- Administration of inferior alveolar nerve block and long buccal infiltration: Septocaine® and epinephrine 1:100,000 (Articaine HCl. 4% and Epinephrine 1:100,000 Injection) at the side of the affected tooth.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Cairo university
-
Contact:
- Aya A AboElMagd, M.Sc
- Phone Number: +201016794067
- Email: aya.aboelmagd@dentistry.cu.edu.eg
-
Contact:
- Passant Nagi, Ph.D
- Phone Number: +201280557107
- Email: passant.nagi@dentistry.cu.edu.eg
-
Principal Investigator:
- Hala M Abbas, Professor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Children aged between 8 years and 9.5 years.
- Decayed Mandibular Permanent first molars.
- Symptomatic Mandibular permanent first molar (caries-related pulpal symptoms or hypersensitivity relating to enamel hypo mineralization)
Exclusion Criteria:
- Children who are not apparently healthy.
- Lack of informed consent by the child patient's parent.
- Patients who are allergic to any of the materials used in the procedure.
- Unable to attend follow-up visits.
- Refusal of participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pulpotomy
MTA Pulpotomy
|
Other Names:
|
|
Active Comparator: Extraction
|
After complete Anesthetic application in the affected area, non-surgical extraction will be done.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post operative pain
Time Frame: 24 hours post operatively
|
will be measured using visual analog scale (VAS) The findings suggested that 100-mm VAS ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain.
|
24 hours post operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oral health related quality of life
Time Frame: 12 months
|
will be measured using Child Oral Impact on Daily Performances.
It consists of 25 items distributed among 4 domains: oral symptoms, functional limitations, emotional well-being, and social well-being.
It is self-reported by 8-10-year-old children using a 5-point Likert scale, and responses range from 0-4 for each item.
Total scores range from 0 to100, and higher scores indicate poorer OHRQoL
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical and radiographic success
Time Frame: 12 months
|
clinical absence of signs and symptoms of infection, inflammation, swelling , pain and mobility Radiographic absence of periapical radiolucency
|
12 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2111991
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Irreversible Pulpitis
-
Tehran University of Medical SciencesActive, not recruitingSymptomatic Irreversible Pulpitis (SIP) | Symptomatic Irreversible Pulpitis With Apical PeridontitisIran
-
Cairo UniversityNot yet recruitingPulpitis - Reversible | Pulpitis - Irreversible
-
Mansoura UniversityCompletedIrreversible Pulpitis | Reversible PulpitisEgypt
-
Urooj FatimaNot yet recruitingSymptomatic Irreversible Pulpitis | Irreversible Pulpitis | Asymptomatic Irreversible PulpitisPakistan
-
Cukurova UniversityCompletedPulpitis - IrreversibleTurkey (Türkiye)
-
Misr International UniversityActive, not recruitingPulpitis | Irreversible Pulpitis | Pulpitis - IrreversibleEgypt
-
Postgraduate Medical Institute, LahoreNot yet recruitingIrreversible PulpitisPakistan
-
Cairo UniversityNot yet recruitingPulpitis - Irreversible
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityNot yet recruitingIrreversible PulpitisEgypt
Clinical Trials on MTA pulpotomy
-
Necmettin Erbakan Universitynecmettin erbakan university Scientific Research Projects (BAP)Completed
-
Cairo UniversityUnknownSymptomatic Irreversible Pulpitis
-
University GhentCompleted
-
University of Health Sciences LahoreNot yet recruitingIrreversible Pulpitis | Pulpotomy | MTA Vital Tooth PulpotomyPakistan
-
Cairo UniversityNot yet recruiting
-
Damascus UniversityCompleted
-
sherouk atef elsayedCairo UniversityNot yet recruiting
-
Jordan University of Science and TechnologyActive, not recruiting
-
Cumhuriyet UniversityCompletedSymptomatic Irreversible Pulpitis (SIP)Turkey (Türkiye)